McKesson Corporation (MCK) is a publicly traded Healthcare sector company. As of October 16, 2026, MCK trades at $1,000.62 with a market cap of $113.86B and a P/E ratio of 24.87. MCK moved +0.51% today. Year to date, MCK is +21.28%; over the trailing twelve months it is +26.10%. Its 52-week range spans $598.58 to $1,003.21. Analyst consensus is strong buy with an average price target of $982.00. Rallies surfaces MCK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MCK financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. MCK recently traded at $1,000.62. Market cap is $113.86B. P/E ratio is 24.87. Revenue is $410.98B.
| Metric | Value |
|---|---|
| Price | $1,000.62 |
| Market Cap | $113.86B |
| P/E Ratio | 24.87 |
| EPS | $37.47 |
| Dividend Yield | 0.94% |
| 52-Week High | $1,003.21 |
| 52-Week Low | $598.58 |
| Volume | 130.75K |
| Avg Volume | 0 |
| Revenue (TTM) | $410.98B |
| Net Income | $5.30B |
| Gross Margin | 3.64% |
14 analysts cover MCK: 0 strong buy, 11 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $982.00.